Package 69315-912-01

Brand: oxazepam

Generic: oxazepam
NDC Package

Package Facts

Identity

Package NDC 69315-912-01
Digits Only 6931591201
Product NDC 69315-912
Description

100 CAPSULE in 1 BOTTLE (69315-912-01)

Marketing

Marketing Status
Marketed Since 2025-07-09
Brand oxazepam
Generic oxazepam
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "708e4237-a898-4d23-90b1-253c18301884", "openfda": {"nui": ["N0000175694", "M0002356"], "upc": ["0369315913017"], "unii": ["6GOW6DWN2A"], "rxcui": ["198057", "198059", "312134"], "spl_set_id": ["67f821fa-5663-4d69-82c9-5ee13a09f324"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "manufacturer_name": ["Leading Pharma, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (69315-912-01)", "package_ndc": "69315-912-01", "marketing_start_date": "20250709"}], "brand_name": "OXAZEPAM", "product_id": "69315-912_708e4237-a898-4d23-90b1-253c18301884", "dosage_form": "CAPSULE", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]"], "product_ndc": "69315-912", "dea_schedule": "CIV", "generic_name": "OXAZEPAM", "labeler_name": "Leading Pharma, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OXAZEPAM", "active_ingredients": [{"name": "OXAZEPAM", "strength": "15 mg/1"}], "application_number": "ANDA218261", "marketing_category": "ANDA", "marketing_start_date": "20250709", "listing_expiration_date": "20261231"}